Friday, July 10, 2026

Drug profile · INN

mercaptamine

mercaptamine (PROCYSBI) is an FDA-listed pharmaceutical active ingredient.

EMA: approved Alimentary tract and metabolism (A16) A16AA04
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — mercaptamine
Class
Alimentary tract and metabolism (A16)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

mercaptamine (PROCYSBI) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN mercaptamine
Brand PROCYSBI
Therapeutic class Alimentary tract and metabolism (A16)
ATC code A16AA04

Approval history

Authority Status Date
EMA approved

Related & competitor drugs

  1. agalsidase alfa Alimentary tract and metabolism (A16)
  2. alogliptin Alimentary tract and metabolism (A10)
  3. alogliptin benzoate Alimentary tract and metabolism (A10)
  4. aprepitant Alimentary tract and metabolism (A04)
  5. budesonide Alimentary tract and metabolism (A07)
  6. canagliflozin Alimentary tract and metabolism (A10)

Frequently asked questions

What is mercaptamine?

mercaptamine (PROCYSBI) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for mercaptamine?

PROCYSBI is a marketed brand name for mercaptamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.